NUVB Nuvation Bio Inc

Price (delayed)

$5.31

Market cap

$1.85B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.42

Enterprise value

$1.95B

?
Relative Growth: Rel. Growth: 76
Relative Strength: Rel. Strength: 72
Relative Valuation: Rel. Valuation: 9
Relative Profitability: Rel. Profitability: 41

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and ...

Highlights
The gross profit has soared by 142% from the previous quarter
Nuvation Bio's revenue has soared by 127% from the previous quarter
NUVB's equity is down by 24% year-on-year but it is up by 4.5% since the previous quarter
The company's quick ratio fell by 20% YoY but it rose by 6% QoQ

Key stats

What are the main financial stats of NUVB

NUVB stock price

How has the Nuvation Bio stock price performed over time
Intraday
12.5%
1 week
11.79%
1 month
20.41%
1 year
116.73%
YTD
-40.74%
QTD
23.78%

Financial performance

How have Nuvation Bio's revenue and profit performed over time
Revenue
$143.05M
Gross profit
$129.85M
Operating income
-$150.18M
Net income
-$145.99M
Gross margin
90.8%
Net margin
-102.1%
The gross profit has soared by 142% from the previous quarter
Nuvation Bio's revenue has soared by 127% from the previous quarter
The operating margin has soared by 98% YoY and by 69% QoQ
Nuvation Bio's net margin has surged by 98% YoY and by 69% QoQ

Price vs fundamentals

How does NUVB's price correlate with its fundamentals

Growth

What is Nuvation Bio's growth rate over time

Valuation

What is Nuvation Bio stock price valuation
P/E
N/A
P/B
5.78
P/S
12.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.6
NUVB's EPS has soared by 81% YoY and by 30% QoQ
The stock's price to book (P/B) is 133% more than its 5-year quarterly average of 2.2
NUVB's equity is down by 24% year-on-year but it is up by 4.5% since the previous quarter
Nuvation Bio's revenue has soared by 127% from the previous quarter
The price to sales (P/S) is 70% less than the last 4 quarters average of 38.2

Efficiency

How efficient is Nuvation Bio business performance
NUVB's ROS has soared by 98% YoY and by 71% QoQ
The return on invested capital has surged by 83% year-on-year and by 40% since the previous quarter
NUVB's return on assets has surged by 78% year-on-year and by 32% since the previous quarter
NUVB's ROE has soared by 70% YoY and by 23% from the previous quarter

Dividends

What is NUVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUVB.

Financial health

How did Nuvation Bio financials performed over time
The company's total assets is 110% higher than its total liabilities
The company's total assets rose by 24% YoY and by 2.6% QoQ
The company's quick ratio fell by 20% YoY but it rose by 6% QoQ
Nuvation Bio's debt is 32% lower than its equity
NUVB's equity is down by 24% year-on-year but it is up by 4.5% since the previous quarter
The debt to equity fell by 2.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.